systemic-lupus-erythematosus

Documents about systemic-lupus-erythematosus

• COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders#217105ClinicalTrials.gov
• Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V#870100ClinicalTrials.gov
• KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis#847923ClinicalTrials.gov
• Comparison of Evans syndrome and isolated autoimmune cytopenias in SLE: a retrospective study#15458HAL (France)
• The Shiho Immune Harmony Protocol: Metacognitive AI for Self-Attack Resolution in Systemic Lupus Erythematosus – Protocol Design, Mathematical Foundations, and Patient-Facing Mobile Application#106128PhilArchive
• [Jianpi Zishen Formula improves renal damage in mice with systemic lupus erythematosus by inhibiting p53-MDM2 signaling axis-mediated ferroptosis].#143173NCBI PubMed Central
• The 2026 British Society for Rheumatology guideline for the management of children, young people and adults with systemic lupus erythematosus.#312607NCBI PubMed Central
• A Feed-Forward Loop Between Extrafollicular B Cell Differentiation and the Inflammatory Milieu Governs Remission and Relapse in Systemic Lupus Erythematosus#438518bioRxiv / medRxiv
• Early creatinine dynamics for stratifying acute kidney injury trajectories in patients with systemic lupus erythematosus: an exploratory multicenter retrospective study.#630896NCBI PubMed Central
• Development and temporal validation of a clinical prediction model to identify bacterial infection in hospitalised patients with systemic lupus erythematosus.#671008NCBI PubMed Central
• ILD-SARDs Registry and Biorepository#870071ClinicalTrials.gov
• Associated factors of health-related quality of life in Indonesian Women with Systemic Lupus Erythematosus: A cross-sectional within-cohort analysis.#135583NCBI PubMed Central
• Assessment of long-term damage and cardiovascular risk in juvenile systemic lupus erythematosus compared to juvenile dermatomyositis in adulthood#154108Unpaywall
• Quantitative mapping of prefrontal oxygenation dysfunction and neuropsychiatric symptoms in patients with systemic lupus erythematosus: a multichannel functional near-infrared spectroscopy study.#340327NCBI PubMed Central
• Old marker, new face: anti-RNP as a sentinel of coronary and peripheral endothelial dysfunction in systemic lupus erythematosus.#340410NCBI PubMed Central
• Characterization of the patterns of care, access, and direct cost of systemic lupus erythematosus in Brazil: findings from the Macunaíma study.#472633NCBI PubMed Central
• A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Diseases#904848ClinicalTrials.gov
• Data of indirect immunofluorescence labeling of the mouse brain sections with sera from SLE and MS patients#955030Koc University Digital Collections
• The private truncating Toll-like receptor 7 p.Glu834* variant associates with juvenile-onset systemic lupus erythematosus and pathological cytokine expression in vitro#1039001HAL (France)
• An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases#854779ClinicalTrials.gov
• Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases#1029879ClinicalTrials.gov
• Supplementary Material for: Comparative Efficacy and Safety of Telitacicept vs. Belimumab in Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis#357066Figshare
• Stigma, discrimination-related events, and determinants among adult people living with systemic lupus erythematosus (SLE): Systematic review and indicator-level meta-analysis.#796702NCBI PubMed Central
• Monıtorıng Glucocortıcoıd Treatment In Patıents Followed In Rheumatology Clınıc#810113ClinicalTrials.gov
• Does Belimumab Modify the Natural History of SLE? A Propensity Score-matched, Real-world Study#1045555ClinicalTrials.gov
• Study of Safety, Efficacy and Tolerability of Secukinumab Versus Placebo, in Combination With SoC Therapy, in Patients With Active Lupus Nephritis#918011ClinicalTrials.gov
• A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK2586184 and the Effect of Food and Gender#810816ClinicalTrials.gov
• Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases#217044ClinicalTrials.gov
• Prevalence and psychosocial correlates of depression, anxiety and stress among caregivers of children with childhood-onset systemic lupus erythematosus in China: a cross-sectional study.#265268NCBI PubMed Central
• Impact of Early Antimalarial Adherence on Future Acute Care Utilization and Cost Among Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Population-Based Study.#323094NCBI PubMed Central
• Achievement of real-world adapted DORIS remission targets among patients with systemic lupus erythematosus initiating belimumab in the USA: A retrospective, observational, cohort study.#785595NCBI PubMed Central
• Prevalence and Seroconversion of COVID-19 in Autoimmune Diseases in Europe#801315ClinicalTrials.gov
• UCAR T-cell Therapy Targeting CD19/ BCMA(QT-019C) in Patients With Relapse/ Refractory Autoimmune Diseases#834960ClinicalTrials.gov
• Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II)#1033335ClinicalTrials.gov
• A Trial in Healthy Adult Participants and Adults With Autoimmune Disease to Test How HBM7020 is Tolerated and Absorbed in the Body#916742ClinicalTrials.gov
• Phenomics in Autoimmune and Inflammatory Diseases#158131ClinicalTrials.gov
• Analytical and Clinical Validation of a Remote Laboratory Test for Prothrombin Time and INR Determination in Patients with Antiphospholipid Antibody Syndrome and Systemic Lupus Erythematosus.#199189NCBI PubMed Central
• Secukinumab in Hidradenitis Suppurativa With Concomitant Systemic Lupus Erythematosus and Advanced Kidney Disease: A Case Series Exploring the Il-17 Skin-Kidney Axis.#446135NCBI PubMed Central
• Epigenetic pacemaker: A review of DNA methylation, histone lactylation, and non-coding RNAs in autoimmune skin diseases#780674Europe PMC
• An Exploratory Clinical Study of SCAR02 Targeting BCMA and CD19 for the Treatment of Refractory Autoimmune Diseases#993920ClinicalTrials.gov
• Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune Diseases#914642ClinicalTrials.gov
• Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires#993120ClinicalTrials.gov
• The Study of Comparing the Efficacy and Safety of Human Umbilical Cord MSCs and Low-dose IL-2 in the Treatment of LN#1009920ClinicalTrials.gov
• Therapeutic plasma exchange across multiple organ systems in an Egyptian tertiary center: A seven-year real-world cohort study#686588PLOS
• Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases#855223ClinicalTrials.gov
• Efficacy and Safety of Simvastatin-ezetimibe Combination Therapy Among Patients With SLE#864476ClinicalTrials.gov
• Shotgun Mass Spectrometry-based Lipid Profiling in Chronic Inflammatory Diseases#889033ClinicalTrials.gov
• Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.#904975ClinicalTrials.gov
• The Relationship between the Number of Major Organ Involvement and Therapeutic Response of Pulse Dose Methylprednisolone in Systemic Lupus Erythematosus Patients#930439Acta Interna: The Journal of Internal Medicine
• Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions#152605ClinicalTrials.gov